John Klimowich, Senior Executive Vice President and Chief Risk Officer of Columbia Financial, Inc./MD/, filed a Form 4 on August 25, 2026, reporting a transaction dated August 21, 2026, in shares of NASDAQ:CLBK common stock.

Key Highlights

  • Phantom stock acquired: Klimowich acquired 58.0679 phantom stock units on August 21, 2026, at a price of $11.79 per unit through the Columbia Bank Stock Based Deferral Plan.
  • Post-transaction indirect holdings via deferral plan: Following the transaction, the deferral plan account holds 20,522.7185 units of common stock indirectly.
  • Direct holdings: The filing reports 145,056 shares of common stock held directly.
  • Additional indirect holdings: Shares are also held indirectly through a 401(k) (67,686), SERP (16,779), ESOP (19,117), SIM (9,269), Stock Award III (24,135), Stock Award IV (25,790), and Stock Award V (26,193).
  • Stock options outstanding: Klimowich holds stock options to purchase a total of 549,234 shares of common stock across five grants with exercise prices ranging from $7.10 to $8.31.
  • Non-discretionary acquisition: According to the filing, the purchase was made "on a non-discretionary basis, by the trustee of the Bank's rabbi trust" and will be "settled in shares of stock upon distribution to the reporting person."

Klimowich's Deferral Plan Purchase and Full Beneficial Ownership at Columbia Financial

According to the filing, John Klimowich, in his role as SEVP and Chief Risk Officer of Columbia Financial, Inc./MD/ (NASDAQ:CLBK), reported a single acquisition transaction. On August 21, 2026, the trustee of the Columbia Bank rabbi trust purchased 58.0679 phantom stock units at $11.79 per unit on a non-discretionary basis under the Columbia Bank Stock Based Deferral Plan. After the transaction, the deferral plan account holds 20,522.7185 units indirectly. The filing states that these stock unit interests will be settled in shares of common stock upon distribution to the reporting person.

Beyond the deferral plan, the filing discloses that Klimowich holds 145,056 shares of common stock directly. Indirect holdings span multiple benefit vehicles: 67,686 shares through a 401(k), 16,779 through a SERP, 19,117 through an ESOP, and 9,269 through a SIM account. Three equity award tranches are also listed: Stock Award III (24,135 shares), Stock Award IV (25,790 shares), and Stock Award V (26,193 shares). Awards IV and V vest upon the achievement of certain specified performance-based criteria, with potential vesting on March 3, 2028, and March 2, 2029, respectively, according to the filing.

The filing also reports five stock option grants in Table II. Two grants, with exercise prices of $7.10 and $7.25, are described as "fully vested and exercisable," covering 414,117 and 26,466 shares, respectively. Three additional option grants, at $7.50, $7.38, and $8.31, covering 19,470, 44,682, and 44,499 shares, vest in three approximately equal annual installments commencing on March 6, 2025, March 3, 2026, and March 2, 2027, respectively. The form was signed by Thomas F. Splaine, Jr., pursuant to a power of attorney, on August 25, 2026.

What Was Disclosed

The filing reports a single non-discretionary acquisition of 58.0679 phantom stock units at $11.79 by the Columbia Bank rabbi trust on behalf of Klimowich, along with a full snapshot of his direct and indirect beneficial ownership of Columbia Financial common stock and outstanding stock options.